Novo Nordisk A/S (Novo Nordisk A/S) Cash Flow for Dividends

: $-4,560 Mil (TTM As of Dec. 2023)

View and export this data going back to 1981. Start your Free Trial

Novo Nordisk A/S's cash flow for dividends for the three months ended in Dec. 2023 was $0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2023 was $-4,560 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Novo Nordisk A/S's quarterly payment of dividends increased from Jun. 2023 ($0 Mil) to Sep. 2023 ($-1,922 Mil) but then declined from Sep. 2023 ($-1,922 Mil) to Dec. 2023 ($0 Mil).

Novo Nordisk A/S's annual payment of dividends increased from Dec. 2021 ($-3,270 Mil) to Dec. 2022 ($-3,603 Mil) and increased from Dec. 2022 ($-3,603 Mil) to Dec. 2023 ($-4,648 Mil).

Novo Nordisk A/S Cash Flow for Dividends Historical Data

The historical data trend for Novo Nordisk A/S's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

-2,887.00

-3,290.22

-3,269.56

-3,602.93

-4,647.83

Novo Nordisk A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash Flow for Dividends																-	-2,637.58	-	-1,921.95	-

Novo Nordisk A/S Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4,560 Mil.

Novo Nordisk A/S Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk A/S (Novo Nordisk A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (NYSE:NVO) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

NONOF:USA NOVOB:Mexico NVO:Mexico NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany N1VO34:Brazil NNO2:Austria

Address

Novo Alle 1, Bagsvaerd, DNK, DK-2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.